Furthermore, the production of IL-8 in PMNs is NF-κB dependent. We have further identified that interleukin-6 (IL-6) and interleukin-1β (IL-1β) from PMN-melanoma co-cultures synergistically contribute to IκB-α degradation and IL-8 synthesis in PMNs. Taken together, these findings show that melanoma cells induce PMNs to secrete IL-8 through activation of NF-κB and suggest a model in which this interaction promotes a microenvironment that is favorable for metastasis.
Introduction
The induction and release of cytokines and chemotactic cytokines (chemokines) that result from inflammation directly influence tumor metastasis, the course of cancer and associated diseases. Metastasis is a sequential process in which a tumor cell is required to transmigrate through the endothelium; an event that necessitates the tumor cell to undergo extensive interactions with host cells [1] . Human polymorphonuclear neutrophils (PMNs), which function as professional phagocytes and are important source of cytokines, actively participate in inflammatory responses and facilitate tumor cell extravasation. A recent study has indicated that melanoma cells by themselves cannot effectively adhere to and migrate through the endothelium under flow conditions. However, when PMNs are present, melanoma cell adhesion and migration are observed [2] . The PMN-facilitated melanoma transmigration correlates with an increase in soluble interleukin-8 (IL-8) production within the melanoma-PMN microenvironment and Mac-1 expression on PMNs [2] . The mechanisms by which melanoma cells and PMNs interact and communicate during metastasis have not been fully elucidated.
Chemokines are a group of peptides with a molecular mass of 8-14 kDa. In addition to their primary function of attracting leukocytes to sites of inflammation, chemokines regulate tumor growth, angiogenesis and metastasis [3] [4] [5] . IL-8 is of particular interest because of its ability to mediate PMN infiltration through CXC chemokine receptors 1 and 2 (CXCR1 and CXCR2) [5] . Although CXCR1 has not been shown to be expressed in melanoma cells [6] , melanoma cells secrete IL-8, which alters adhesion molecule expression on PMNs. IL-8 regulates ligand binding activity of the β 2 integrins of PMNs [7] , which, through the binding of intracellular adhesion molecule-1 (ICAM-1) of melanoma cells, are important for PMNmediated melanoma transmigration under flow conditions [2] .
IL-8 mRNA expression and IL-8 protein production are triggered by various stimuli, such as lipopolysaccharide (LPS), tumor necrosis factor (TNF)-α and interleukin-1β (IL-1β) [8, 9] . Accumulating evidence indicates that the transcription of IL-8 gene requires the activation of nuclear factor κB (NF-κB), NF-IL-6 (C/EBPβ) or activator protein (AP)-1 [9] [10] [11] [12] [13] [14] . Activation of NF-κB has been shown to be indispensable for IL-8 synthesis [13] . Upon activation, NF-κB inhibitor, IκB is proteolytic degraded and dissociates from NF-κB dimers, thereby allowing NF-κB translocation to the nucleus and binding to target genes [15] . Although a role for NF-κB in regulating IL-8 expression has been reported, whether NF-κB is required for melanomadependent IL-8 production from PMNs remains unclear. In addition to IL-8, IL-1β, interleukin-6 (IL-6), and GRO have been shown to regulate the immune response and modulate tumor behavior [4, 11, 16] . In this study, we have found that melanoma cells induce IL-8 synthesis from PMNs through activation of NF-κB. Furthermore, IL-8, IL-1β and IL-6 have been shown to participate in inducing IL-8 expression in PMNs. [18] were cultured respectively in Dulbecco's Modified Eagle's Medium (DMEM) and DMEM-F12 (Biosource, Inc.) supplemented with 10% FBS in a standard cell culture condition (5% CO 2 /37°C). Correlation of tumor metastatic potentials with melanoma cell invasiveness, chemotactic migration and adhesiveness is shown in Table 1 . Fibroblast L-cells that had been transfected to express human E-selectin and ICAM-1 (EI cells; provided by Dr. Scott Simon, University of California, Davis, CA) were maintained in culture as described elsewhere [19] . For experiments, culture medium was removed and fresh RPMI 1640 medium with 5% FBS was added. The melanoma cells were cultured alone, Transwell (Sigma Chemical Co., St Louis, MO) cultured or contact cultured with human PMNs in 1: 3 ratio at 37°C.
Material and methods

Cell culture and preparation
Isolation and culture of human PMNs
Fresh human blood was drawn from healthy donors under informed consent as approved by the Pennsylvania State University Institutional Review Board. PMNs were separated from blood using Ficoll-Hypaque (Histopaque; Sigma Chemical Co.). After centrifugation at 620 × g for 30 min, PMNs were carefully isolated and suspended in Dulbecco's phosphate-buffered saline (DPBS) with 0.1% human serum albumin (HSA; Sigma Chemical Co.). Erythrocytes were lysed using ACK lysis buffer (0.15 M NH 4 Cl, 10 mM KHCO 3 , 0.1 mM Na 2 EDTA; [pH 7.4]) and removed. The cells were washed and resuspended in 0.1% HSA/DPBS, and gently rocked until they were used in experiments. The cell preparations were 99.5% pure PMNs, as analyzed by a DiffQuick stain (Dade Behring Inc., Newark, DE). PMNs were resuspended in RPMI 1640 medium supplemented with 5% FBS and cultured with or without melanoma cells. For PMN and melanoma cell co-culture, PMNs were added to the confluent melanoma cells, either directly or separated by a Transwell insert with 0.4 μm pore size. In some experiments, PMNs were stimulated with recombinant human IL-8 (12.5, 25 or 125 ng/ml), IL-1β (5, 10 or 25 ng/ml), IL-6 (50 or 100 ng/ml), GRO-α (100 or 200 ng/ml) (Biosource, Inc.) or a cocktail of IL-1β, IL-6 and GRO-α cytokines. Metastatic potential was qualitatively determined by references listed; chemotactic potential was determined by cell migration towards soluble CIV (100 μg/ml) using Boyden chamber; and adhesion molecules were measured by ICAM-1 expression on cells upon TNF-α stimulation (10 U/ml; 24 h); which are represented by "−", "+", "++" and "+++", for negative, moderate-positive, high-positive and extremely high-positive, respectively.
Pharmacological inhibitors and antibodies
PMNs were pretreated with 100 μM pyrrolidinedithiocarbamate (PDTC; Calbiochem, San Diego, CA) for 1 h to inhibit NF-κB, and the cells were then washed and co-cultured with melanoma cells for 6 h. For anti-human CXCR1 and antihuman CXCR2 (Sigma Chemical Co.) pretreatment, cells were incubated in culture medium containing 0.5 μg/ml anti-CXCR1 and 15 μg/ml anti-CXCR2 monoclonal antibodies (mAbs) for 30 min at 37°C. In GRO-α, IL-1β and IL-6 neutralization studies, cells were exposed to culture medium containing 1 μg/ml anti-human GRO-α, IL-1β and IL-6 (R&D Systems, Inc.) for 6 h at 37°C. Cell viability was verified using trypan blue showing that >95% of PMNs were alive at the end of these assays. 
Western blots
ELISA
At the end of assays, cell-free supernatants were collected by a centrifugation at 430×g for 5 min and stored at − 80°C until enzyme-linked immunosorbent assay (ELISA) was performed. ELISA detection of protein secretion was performed at the Pennsylvania State University NIH Cytokine Core Lab. Mouse anti-human capture antibody to specific target chemokine or cytokine was diluted to 2 μg/ml in coating buffer (0.1 M NaHCO 3 [pH 8.2]) and 50 μl was added to each well of the 96-well ELISA plate for overnight incubation at 4°C. The plate was then washed four times with 20% Tween 20 in phosphate-buffered saline (PBST) [pH 7.0] and blocked with 1% BSA in PBS for 2 h at room temperature. 100 μl target chemokine or cytokine standards and samples were added to each well for overnight incubation at 4°C. The plate was washed four times next day and 100 μl of 0.2 μg/ml biotinylated affinity purified goat antihuman polyclonal detection antibody was added to each well, followed by 2 h incubation at room temperature. The plate was then washed six times and incubated with 10 μl streptavidin peroxidase (1 μg/ml, Sigma Chemical Co.) for 30 min at room temperature. 100 μl of 2,2′-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (Sigma Chemical Co.)/ peroxide substrate solution was then added for 1 h in the dark. The plate was read using a microtiter plate reader (Packard, Downers Grove, IL) at a wavelength of 405 nm.
Flow-migration chamber assay
Flow-migration assay was carried out in a modified 48-well chemotactic Boyden chamber (Figs. 1A and B) [20, 21] . In brief, the polycarbonate chamber consists of a top and bottom plate separated by a gasket. The bottom plate has 48 centered chemotactic wells and screws around the perimeter to affix the top plate. The top plate has an inlet and outlet allowing for circulating flow through the chamber. PVP-free polycarbonate filters (8 μm pore size; NeuroProbe, Gaithersburg, MD) were sterilized and coated with fibronectin (30 μg/ml, 3 h) (Sigma Chemical Co.). Prior to each experiment, a monolayer of EI cells was grown nearly to 100% confluence on prepared filters. The chamber's center 12 wells were filled with soluble chemoattractant, collagen-type IV (CIV; 100 μg/ml in RPMI 1640/0.1% BSA) (BD Biosciences, San Jose, CA) and control wells were filled with medium (RPMI 1640/0.1% BSA). The flow loop was primed with warmed medium to eliminate bubbles in the system. An equal number of PMNs and melanoma cells (a total of 10 6 cells) were put in the chamber. Experiments were run for 4 h in a 37°C, 5% CO 2 incubator. At the end of the assay, the flow chamber was removed from the flow loop and disassembled, and the filter was stained with Protocol Brand Hema3 solution (Fisher Scientific, Pittsburgh, PA). Cells on the top of the filter were removed by scraping. In IL-8 neutralization study, 1 μg/ml anti-human IL-8 (R&D Systems, Inc.) was added into the flow loop during the entire flow-migration assay.
Statistical analysis
All results are shown using mean ± standard error of the mean (SEM) unless otherwise stated. One-way ANOVA analysis was used for multiple comparisons and t-tests were used for comparisons between two groups. P < 0.05 was considered to be significant.
Results
PMN-facilitated melanoma cell extravasation under flow conditions
Correlation of tumor metastatic potentials with melanoma cell invasiveness, chemotactic migration and adhesiveness in term of ICAM-1 expression is shown in Table 1 . Melanoma cell chemotactic migration through EI cells in response to CIV (100 μg/ml) was characterized using a flow-migration chamber under both static and flow conditions (Fig. 1) . EI cells were fibroblast L-cells transfected to constitutively express ICAM-1 and E-selectins used to mimic IL-1β-stimulated human endothelial cells. EI cells did not secrete any cytokine/ chemokine (data not shown). As a negative control, nonmetastatic NHEM (melanocytes) migration was first tested under static conditions towards CIV and found to be near or at a background level (data not shown). In comparison, 1205Lu, WM9 and C8161 were highly migratory under static conditions. A fourth melanoma cell line, WM35, had lower ICAM-1 expression (data not shown) and modest ability to migrate towards CIV under the static conditions, and the number of cells that migrated was significantly less when compared to the three other melanoma cell lines suggesting that WM35 had low adhesiveness and metastatic potential (Fig. 1C) . When exposed to a shear flow (0.4 dyn/cm 2 ), none of the cell lines were able to efficiently extravasate. Importantly, the ability of 1205Lu, WM9 and C8161 to migrate under shear stress was rescued by the addition of PMNs while WM35 had only a modest change (Fig. 1D) . These results indicate that PMNs significantly facilitate melanoma cell migration through the endothelium under flow conditions.
Co-culturing PMNs with melanoma cells induces IL-8
In order to determine the relationship between tumor metastatic potential and cytokine expression in melanoma-PMN co-cultures, four human melanoma cell lines, 1205Lu, WM9, C8161 and WM35, were tested for their abilities to induce cytokine and chemokines in melanoma-PMN co-cultures. These cell lines have a range of metastatic potentials as reported in the literature as well as determined by migration assays (Table 1) , with 1205Lu being the most metastatic, WM9 and C8161 more intermediate in their ability to extravasate and WM35 having the lowest metastatic potential of all four lines. A correlation was found between metastatic potentials of melanoma cells and IL-8 secretion profiles (Fig. 2A) . PMNs co-cultured either in a Transwell or in direct-contact with 1205Lu, WM9 and C8161 increased IL-8 expression above the summed background level, and co-culturing PMNs with WM35 did not induce IL-8 production. In addition, co-culturing of 1205Lu and WM9 with PMNs induced IL-8 production in a time-dependent manner (Fig. 2B) . In contrast, the IL-8 production from WM35 and PMN co-culture did not change over time. The induction of IL-8 was comparable whether cells were cultured in direct-contact or separated in a Transwell culture system indicating that melanoma cells modified PMNs activity through a soluble factor. 
Melanoma cells induce IL-8 expression in PMNs
In order to identify which cell type contributed to the increased amount of IL-8 in PMN-melanoma co-cultures, cell lysates were prepared from PMNs and melanoma cells following Transwell co-culture, and levels of IL-8 were detected by Western blots. As shown in Fig. 3 
NF-κB activity is required in melanoma-induced IL-8 production in PMNs
To obtain insight into how melanoma cells signal and alter PMN function, we initially examined activation of NF-κB signaling following co-cultures. Levels of IκB-α in PMNs, which is degraded upon activation of NF-κB signaling to release NF-κB, were monitored by Western blots. As shown in Fig. 4 , IκB-α protein was degraded within 15 min upon coculturing PMNs with 1205Lu. Similarly WM9 and C8161 induced degradation of IκB-α in PMNs in a time-dependent manner (data not shown). No changes in IκB-α were observed in PMNs cultured in the absence of metastatic melanoma cell lines or with WM35 cells (data not shown). These data would suggest that metastatic melanoma cells induce PMN NF-κB activation. In order to corroborate the role of NF-κB in regulating IL-8 production in PMNs, we pretreated PMN with PDTC, a NF-κB inhibitor, for 1 h at 37°C. The amount of IL-8 protein in the presence of PDTC was reduced to summed background levels in the co-cultures (Fig. 5A) . Furthermore, PDTC suppressed IL-8 protein expression in PMNs following co-culturing with 1205Lu and WM9 as determined by Western blot for IL-8 (Fig.  5B) . Therefore, activity of NF-κB was required for IL-8 induction in PMNs.
Cytokines produced from PMN and melanoma cell cultures
Induction of IL-8 in PMNs after co-culturing with metastatic melanoma cells in a non-contact (Transwell) culture system implies that soluble factors play a critical role in the regulation of IL-8 production. To determine the potential factors in the system, a human cytokine array (Raybiotech, Inc., Norcross, GA) was performed to detect forty-two cytokines, chemokines and growth factors from supernatants obtained from cultures of individual cell types or co-cultures in either direct contact or separation using Transwells. Expressions of GRO, IL-1β, IL-6, IL-8 and MCP-1 were identified from the protein array screen (data not shown) and ELISAs were then used for quantitative profiling of the protein expressions. For all four melanoma cell lines tested, GRO-α (Fig. 6A) and MCP-1 (data not shown) were constitutively expressed and co-culturing with PMNs did not change their expressions. Modest amount of IL-1β was produced by PMNs or melanoma cells cultured alone. It was slightly increased after 1205Lu, WM9 and C8161 were co-cultured with PMNs (Fig. 6B) . In addition, co-culture of PMNs with highly metastatic 1205Lu cells significantly induced IL-6 above the summed IL-6 from separate cultures (Fig. 6C) . These data suggest that the interaction between melanoma cell lines and primary PMNs altered the production of IL-1β and IL-6, in addition to IL-8.
IL-1β and IL-6 induce IL-8 production in PMNs
To investigate the potential role of different cytokines/ chemokines in the melanoma-PMN co-culture system in IL-8 production in PMNs, human recombinant proteins including GRO-α, IL-6 and IL-1β were used to stimulate PMNs. Results indicated that none of these cytokines or chemokines alone was sufficient to induce IL-8 production compared with untreated PMNs (Fig. 7A) . However, stimulating cells with the combination of IL-1β and IL-6 increased IL-8 production in PMNs (Fig. 7A) . Addition of GRO-α together with IL-1β and IL-6 combination did not further increase IL-8. We have also shown that IL-1β and IL-6 induced IκB degradation within 15 min upon stimulation (Fig. 7B) . Therefore, IL-1β and IL-6 act synergistically to increase IL-8 synthesis in PMNs in response to melanomas.
Paracrine stimulation of IL-8 in PMNs co-cultured with melanoma cells
In order to determine if IL-8 was responsible for the increase in IL-8 expression, human recombinant IL-8 at concentrations of 12.5, 25 and 125 ng/ml was added to the PMNs. After washing out the IL-8 used to stimulate PMNs, intracellular IL-8 was monitored in PMNs by Western blot. As shown in Fig. 8A , addition of IL-8 to the cell culture medium was sufficient to significantly induce intracellular IL-8, compared with untreated PMNs.
To confirm that endogenously produced IL-8 induces IL-8 in PMNs, PMNs were pretreated with anti-CXCR1 and CXCR2 mAbs to block the IL-8 receptors. The amount of IL-8 protein found in the presence of anti-CXCR1 and CXCR2 was reduced compared with the untreated PMN and 1205Lu cocultures (Fig. 8B) . In addition, we have also confirmed the roles of IL-1β and IL-6 in the melanoma-mediated IL-8 induction by showing that IL-8 was decreased in the presence of neutralizing antibody against IL-1β and IL-6 (Fig. 8B) . Mouse anti-IgG was used as a negative control showing that there is no significant difference from co-culture case. Most importantly, melanoma cell-induced IL-8 was totally inhibited by anti-CXCR1 and CXCR2 as well as anti-IL-1β and IL-6 indicating the redundancy of signaling pathways that regulate IL-8 production (Fig. 8B) .
IL-8 is required in PMN-facilitated melanoma cell extravasation
To further elucidate the role of IL-8 produced by PMNs and melanoma cells in melanoma-PMN communication, melanoma cell migration was evaluated in the absence or presence of anti-IL-8 (1 μg/ml) and anti-CXCR1 plus CXCR2 under flow conditions. PMN-facilitated melanoma cell extravasation dramatically decreased under 0.4 dyn/cm 2 shear stress in the presence of anti-IL-8 or anti-CXCR1 plus CXCR2 as shown in Fig. 9 . These results indicate that PMN-mediated melanoma migration is modulated by endogenously produced IL-8. 
Discussion
In this study, we have demonstrated that IL-8 is induced in human PMNs that have been co-cultured with metastatic melanoma cells. IL-8 plays an important role in modulating PMN-facilitated melanoma cell extravasation under flow conditions. In addition, melanoma cells induce degradation of IκB-α. A role for NF-κB in regulating IL-8 production has been demonstrated by using a pharmacological inhibitor. Cytokines IL-6 and IL-1β, as well as IL-8 from co-culture media, provide a co-stimulatory signal for the IL-8 induction in PMNs. Taken together, these findings suggest that the production of soluble mediators in response to PMN-melanoma interactions leads to the induction of IL-8 transcription by PMNs, creating a favorable microenvironment for metastasis. IL-8 plays a crucial role in regulating cell function for host defense and natural immunity [9] . IL-8 is released by various cell types, including PMNs, monocytes, T lymphocytes and endothelial cells, upon exposure to inflammatory stimuli, such as TNF-α, IL-1 and LPS [8, 9, 22] . IL-8, in particular, is a major mediator of PMN activation and migration. IL-8 has been previously shown to activate Mac-1 up-regulation in PMNs which facilitates melanoma cell migration under flow conditions [21] . Consistent with this observation, we have also found that IL-8 neutralization leads to a reduction in melanoma transmigration.
Melanoma cells have been reported to express IL-8 and this influences their oncogenic properties [23] , including their metastatic abilities. In the current study, we have shown that IL-8 is constitutively produced by melanoma cells regardless of their metastatic potentials. Furthermore, PMNs do not influence IL-8 expression in melanoma cells. However, tumor metastatic potentials were directly related to the ability of the melanoma cells to induce IL-8 production in PMNs. IL-8 has been shown to induce Mac-1 expression in PMNs [21] ; therefore, melanoma cells with high metastatic potentials (1205Lu, WM9 and C8161) directly alter the microenvironment by modifying PMN function and expression of chemokines and integrins to promote extravasation through β 2 -ICAM-1 bindings under flow conditions, while there is no significant effect under static conditions [21] .
Induction of IL-8 at the site of inflammation requires de novo biosynthesis which is in part regulated by transcriptional activation of the IL-8 gene promoter [13, 24] . In particular, NF-κB is induced upon inflammation to coordinate the expression of a number of cytokine and acute response genes. We used IκB-α as an alternative indicator for NF-κB activity since we had difficulty in getting quality nuclear extract from primary PMNs. Our data show that a melanoma-mediated IL-8 production in PMNs occurs through the activation of NF-κB, as we have observed that IκB-α in PMNs is rapidly degraded when co-cultured with melanoma cells. The activation of NF-κB occurs through the activation of IκB kinase leading to phosphorylation of IκB-α, its subsequent ubiquitination-mediated degradation and concurrent release and nuclear translocation of NF-κB [15] . The pathway appears to be sensitive to PDTC, since PDTC inhibits downstream IL-8 expression from PMNs. NF-κB also plays a crucial role in controlling IL-8 promoter activities in other cell types [10, 13] . In agreement with previous research, we have demonstrated that expression of IL-8 requires NF-κB. Inhibition of NF-κB has also been shown to suppress surface expression of the cell adhesion molecules such as Mac-1 on monocytic HL-60 cells [25] . Therefore, NF-κB might regulate other genes in PMNs that facilitate melanoma cell adhesion and migration.
The promoter for the IL-8 gene has been well characterized and shown to include two cis-regulatory elements, NF-κB and C/EBPβ binding sites, which have been shown to be necessary for IL-8 gene expression [10, 13] . NF-κB and C/EBPβ can be induced by IL-1 and IL-6 [10, 11, 13, 26] . Our data indicate that IL-1β, IL-6 (data not shown) or combination of IL-1β and IL-6 induces IκB degradation but for induction of IL-8 in PMNs both cytokines are required. Therefore, IL-8 synthesis may depend on the strength of NF-κB activation and cooperation with other transcription factors, such as C/EBPβ. Furthermore, we have confirmed the role of combination of IL-1β and IL-6 in the melanoma-mediated IL-8 induction by showing that IL-8 was reduced in the presence of neutralizing antibodies against IL-1β and IL-6. Therefore, melanoma-derived IL-1β and IL-6 act synergistically to regulate IL-8 in PMNs in response to melanomas.
PMN-generated CXC chemokines can act through autocrine or paracrine mechanisms to amplify PMN inflammatory activities via suppression of apoptosis [27] . In the study, paracrine mechanisms are operative since melanoma-derived IL-8 is required for induction of IL-8 in PMNs. IL-8 binds with high affinity to two distinct receptors, CXCR1 and CXCR2. Blocking these two receptors on PMNs significantly reduced IL-8 induction after PMN and melanoma cells are co-cultured, but did not reduce the production of IL-8 to the summed background level of the PMN and melanoma cells indicating that there are cytokines other than IL-8, such as IL-1β and IL-6, . Mouse IgG antibody was used as a negative control. *P < 0.05 with respect to WM35 + PMN case; #P < 0.05 with respect to C8161 + PMN case; **P < 0.05 with respect to WM9 + PMN case; ##P < 0.05 with respect to 1205Lu + PMN case. Values are mean ± SEM for n ≥ 3.
which are responsible for the increase of IL-8 secretion after co-culture.
In summary, we have demonstrated a melanoma cell and cytokine-induced IL-8 production in PMNs though a NF-κB-dependent pathway. The functional significance of IL-8 is that it facilitates the ability of PMNs to assist melanoma cell extravasation. A better understanding in PMN inflammatory activation in response to tumor cells may provide insights into potential cancer therapies.
